Categories: News

GoodRx to Present Virtually at Upcoming Investor Conferences

SANTA MONICA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced that executives from the Company will be presenting at the following virtual investor conferences:

  • Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10, at 11:00 a.m. Pacific Time (2:00 p.m. Eastern Time)
  • Citi 2021 Global Technology Virtual Conference on Tuesday, September 14, at 9:10 a.m. Pacific Time (12:10 p.m. Eastern Time)
  • Goldman Sachs 30th Annual Communacopia Conference on Wednesday, September 22, at 11:55 a.m. Pacific Time (2:55 p.m. Eastern Time)

Live webcasts of all presentations and any accompanying presentation materials, as well as the archived recordings, will be available on the Company’s Investor Relations website, https://investors.goodrx.com/. Following each conference, archived recordings will be available on the Company’s website for at least 30 days.

About GoodRx

GoodRx helps Americans get the healthcare they need at a price they can afford. As America’s leading resource for healthcare savings, GoodRx connects consumers with affordable and convenient prescriptions and medical care, including telehealth, mail order prescriptions, doctor visits, and lab tests. We have helped Americans save over $30 billion since 2011 and we are one of the most downloaded medical apps over the past decade.

Investor Contact
GoodRx
Whitney Notaro
wnotaro@goodrx.com

Press Contact
GoodRx
Lauren Casparis
lcasparis@goodrx.com

Staff

Recent Posts

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers…

31 minutes ago

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

12 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

14 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

14 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

14 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

14 hours ago